loan programs

Evolus strengthens its balance sheet with an investment of $ 25.5 million

Pro forma cash position of $ 57 million as at December 31, 20201 NEWPORT BEACH, Calif., March 23, 2021 (GLOBE NEWSWIRE) – Evolus, Inc. (Nasdaq: EOLS), a successful beauty company with a customer-centric approach focused on delivering breakthrough products, today announced several transactions concluded with its strategic partner Daewoong Pharmaceutical Co. Ltd. (“Daewoong”), which further […]